Evaluation of the bioNexia Legionella Test, Including Impact of Incubation Time Extension, for Detection of Legionella pneumophila Serogroup 1 Antigen in Urine

J Clin Microbiol. 2017 Jun;55(6):1733-1737. doi: 10.1128/JCM.02448-16. Epub 2017 Mar 22.

Abstract

In this study, we compared the bioNexia test (bioMérieux, Marcy-l'Étoile, France), a new immunochromatographic assay for the detection of Legionella pneumophila serogroup 1 in urine, with the BinaxNOW urinary antigen test (Alere, Waltham, Massachusetts, USA). After 15 min of incubation (in accordance with the manufacturers' instructions), the sensitivities and specificities were, respectively, 76.5% and 97.2% for the bioNexia test and 87.1% and 100% for the BinaxNOW test. After a prolonged incubation time of 60 min, the sensitivities and specificities increased to, respectively, 89.4% and 97.2% for the bioNexia test and 91.8% and 100% for the BinaxNOW test. When the tests were read after 15 min, the concentration of discrepant urine samples increased the sensitivities to 94.1% for both tests. In conclusion, we found that although the bioNexia test showed lower sensitivity for the detection of L. pneumophila antigen in nonconcentrated urine compared to the BinaxNOW test, a prolonged incubation time as well as the use of concentrated samples showed comparable sensitivities for both tests.

Keywords: Legionella; Legionnaires' disease; urinary antigen test.

Publication types

  • Evaluation Study

MeSH terms

  • Antigens, Bacterial / analysis*
  • Bacteriological Techniques / methods*
  • Chromatography, Affinity / methods*
  • Humans
  • Legionella pneumophila / isolation & purification*
  • Legionnaires' Disease / diagnosis*
  • Sensitivity and Specificity
  • Serogroup
  • Time Factors
  • Urine / chemistry*

Substances

  • Antigens, Bacterial